Townsville Eye Care Education Seminar
Date: 12/06/2022 (AEST)
Venue: Rydges, 23 Palmer Street, South Townsville, QLD, 4810
Provider: Townsville Eye Care
Contact: Anna Puglisi, [E] optometrists@townsvilleeyecare.com.au, [P] (07) 4775 6686
**Note: Preference will be given to optometrists practicing in North QLD/Far North QLD
Learning Objectives
- 1.1 To become familiar with common retinal vascular diseases
- 1.2 To become familiar with the mechanism of action of retinal laser therapy
- 1.3 To become familiar with the role of retinal laser therapy in the management of retinal vascular disease
- 1.4 To become familiar with the role of Anti-VEGF in the management of retinal vascular disease
- 2.1 To develop an understanding of the mechanism of action of Anti-VEGF agents
- 2.2 To become familiar with the current and more common applications of Anti-VEGF therapy in retinal disease
- 2.3 To become familiar with the new and emerging uses for Anti-VEGF agents
- 3.1 Develop the ability to distinguish meaningful clinical findings
- 3.2 Develop the ability to correlate patient signs and symptoms with the affected ocular systems
- 3.3 Develop the ability to implement appropriate therapeutic management in a variety of ocular conditions
- 3.4 Communicate relevant clinical findings and appropriate management with the patient and other practitioners especially in cases requiring collaborative care
- 4.1 To become familiar with the spectrum of management options for glaucoma
- 4.2 To recognise the societal and patient impact of the long-term treatment for glaucoma
- 4.3 To recognise the need for novel therapeutic and surgical avenues for the management of chronic glaucoma
- 5.1 Develop the ability to detect and diagnose macular telangiectasia
- 5.2 Understand the mechanisms of development of macular telangiectasia
- 5.3 Develop the ability to determine the necessity and expediency of ophthalmological referral in the management of a patient with macular telangiectasia
- 6.1 To become familiar with the novel features of cataract surgery
- 6.2 To become familiar with the range of intraocular lens implantation options available
- 6.3 To identify the patient factors that impact their suitability for cataract surgery and the various intraocular lens options
- 7.1 To become familiar with the field of oculoplastic surgery
- 7.2 To compare and contrast the pathological and cosmetic indicators for oculoplastic surgical intervention
- 7.3 To gain exposure to oculoplastic surgical techniques
Max CPD hours awarded: 6.5
Session Information
Name |
---|
Ophthalmic Case Studies |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.75 |
Name |
---|
Managing Glaucoma - A Marathon not a Sprint |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
0.75 |
Duration of CPD Session/Module inclusive of Assessment Component |
1 |
Name |
---|
Understanding Macular Telangiectasia |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.75 |
Duration of CPD Session/Module inclusive of Assessment Component |
1 |
Name |
---|
What's New in Cataract Surgery |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.75 |
Duration of CPD Session/Module inclusive of Assessment Component |
1 |
Name |
---|
Oculoplastics - More Than Just the Lids |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.75 |
Duration of CPD Session/Module inclusive of Assessment Component |
1 |
Name |
---|
Retinal Laser in the Anti-VEGF Era |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
No |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.75 |
Name |
---|
Novel Applications for Anti-VEGF Therapy - Targeting New Conditions |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
0.75 |
Duration of CPD Session/Module inclusive of Assessment Component |
1 |